Skip to main content
Clinical Trials/CTRI/2015/04/005720
CTRI/2015/04/005720
Other
未知

An exploratory study to assess the effect of topical application of iodex balm on local surface temperature using infra red thermal imaging technique.

GlaxoSmithKline Pharmaceuticals Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
GlaxoSmithKline Pharmaceuticals Limited
Status
Other
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Satisfactory completion of the consent procedure (subject understanding of the study,willingness to participate and receiving of the signed and dated copy of the consent form).
  • 2\. age of the subject should be between 35 to 65\.
  • 3\. Subject understands and is willing, able and likely to comply with all study procedures and restrictions.
  • 4\. Good general and mental health of the subject with, in opinion of the investigator or medically qualified designee
  • a. No clinically significant and relevant abnormalities of medical history or physical examination
  • b. Absence of any condition that would impact on the subject safety or well being or affect the individual ability to understand and follow study procedures and requirements.
  • 5\. Diagnosis subject is suffering from chronic osteoarthritis of knee joint as per ACR criteria for greater than three months.
  • 6\. Females of childbearing potential who are, in the opinion of the investigator, practicing a reliable method of contraception.

Exclusion Criteria

  • 1\. Pregnancy: women who are known to be pregnant or who are intending to become pregnant over the duration of the study or who have a positive urine pregnancy test
  • 2\.Breast\-feeding: Women who are breast\-feeding,
  • 3\. Allergy/Intolerance: Known or suspected intolerance or hypersensitivity
  • to the study materials (or closely related compounds) or any of their stated ingredients,
  • 4\.Subject has current or relevant previous history of serious, severe or unstable physical or psychiatric illness, or medical disorders, such as current or previous history of hepatic ( or renal diseases (impairment) or peptic ulcer as determined by medical history,
  • 5\.Subject has psoriasis and/or active atopic dermatitis/eczema, and skin
  • infected lesions, burn or wound at th application site,
  • 6\.Clinical Study/Experimental Medication:
  • a. Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit,
  • b. Previous participation in this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials